NY AG Letitia James calls for FDA to address potential dangers of asthma and allergy drug Singulair
In a letter to the FDA commissioner, James wrote the drug has been linked to harmful behavioral and mental health issues among children.
News 12 Staff
•
Feb 26, 2024, 10:29 PM
•
Updated 81 days ago
Share:
More Stories
0:37
Swastika drawings found in two classrooms at Sleepy Hollow schools
yesterday1:28
Caught on camera: Family's dog fends off bear in Sullivan County
2ds ago1:41
Croton to flip commuter lot into new housing
2ds ago1:44
White Plains Jewish Agency unveils memorial for massacre victims
4ds ago0:33
Changes to recreational striped bass fishing regulations in the Hudson River
16ds ago0:50
Westchester county executive announces $3 million allocated to build affordable housing in Mamaroneck
16ds ago0:37
Swastika drawings found in two classrooms at Sleepy Hollow schools
yesterday1:28
Caught on camera: Family's dog fends off bear in Sullivan County
2ds ago1:41
Croton to flip commuter lot into new housing
2ds ago1:44
White Plains Jewish Agency unveils memorial for massacre victims
4ds ago0:33
Changes to recreational striped bass fishing regulations in the Hudson River
16ds ago0:50
Westchester county executive announces $3 million allocated to build affordable housing in Mamaroneck
16ds agoThe New York Attorney General Letitia James is calling on the FDA to address the potential dangers of popular asthma and allergy medication Singulair.
In a letter to the FDA commissioner, James wrote the drug has been linked to harmful behavioral and mental health issues among children.
Multiple parents have reported their children having aggressive behavior, intense nightmares and depression while using the drug.
Some even had suicidal thoughts or committed suicide, James wrote in the letter.
The FDA issued a black box warning for Singulair in March 2020 for the same reasons.
